News Well
So you want to be in medical device sales? Really?
Almost every candidate who applies for a medical device sales position says that they’ve always wanted to be in medical device sales. Over time, it’s possible to become rather skeptical of this statement.
One hiring manager said to me, “People sometimes get this idea that medical device sales is a glamorous job. This job is about pushing video carts across slushy parking lots in the middle of winter.”
Breaking into medical device sales is not like hitting the lottery. Don’t expect to coast. Expect to work hard and be challenged to grow professionally like never before.
If you really want to be in medical device sales, are you prepared to…
Genzyme pares Abiomed stake
Clinical trials roundup: Medtronic study to boost CRT-D industry?
Cardiac resynchronization-therapy defibrillators reduced the mortality rate by 29 percent in patients with mild symptoms of heart failure, according to a study released by Medtronic Inc. (NYSE:MDT) at the annual meeting of the American Heart Assn. in Chicago.
Nonprofit takes risk out of device development for Medtronic
For companies like Medtronic Inc. (NYSE:MDT), developing breakthrough technologies to treat untreatable diseases can be expensive and have little promise of financial returns.
The risk is high enough for — even companies as well-resourced as Fridley, Minn.-based Medtronic — that alternative funding sources are welcomed and highly sought after.
Earnings roundup: Derma Sciences increases sales, but dips into red
Derma Sciences increases sales, but dips into red
Derma Sciences Inc. (OTC:DSCI) posted losses of $502,552, or 8 cents per diluted share, on sales of $15.1 million during the three months ended Sept. 30. That compares with profits of $139,603, or 3 cents per share, on sales of $12.9 million during the same period last year.
Agilent’s profits leap 800 percent
Agilent Technologies Inc. (NYSE:A) reported that its 2010 fourth-quarter profit soared more than 800 percent, as orders jumped in all sectors and its acquisition of Varian Inc. began to pay off.
Another mHealth mobile app developer acquired
An emergency response training company owned by Cleveland, Ohio private equity firm The Riverside Co. purchased a developer of smartphone applications that feature emergency care instructions.
Oregon-based Health & Safety Institute has added GoToAID of North Carolina for an undisclosed amount, according to Riverside. The PE firm purchased HSI as a “platform company” in 2006 and has added to it a number of emergency education providers.
Optos offers $15 million for Opto Global shares
Optos plc (LON:OPTS) commenced a proposed takeover of Opto Global Holdings Pty Ltd with an offer worth up to $14.8 million.
The Scotland-based medical retinal imaging device firm wants to build up its product offering in the U.S. and Europe while expanding into Opto Global’s markets "in the Far and Middle East, Australasia, Africa and Latin America," according to the company.
GlucoMetrics says it can beat glucose monitoring competition on accuracy
Diabetics have a problem, and an Ohio startup thinks its technology has what it takes to solve it.
Blood glucose monitoring technology isn’t as accurate as it could be, and that lack of accuracy poses a health risk to diabetics, particularly those suffering from hypoglycemia said Bill Timmons, CEO of Columbus-based GlucoMetrics Inc. The condition can bring fainting or seizures, in serious cases, and occurs when a patient’s blood glucose is too low. It can be brought on by excessive amounts of insulin.
Ecolab buys O.R. Solutions for $260 million
Ecolab Inc. (NYSE:ECL) announced its plans to buy Chantilly, Va.-based O.R. Solutions Inc.
The St. Paul, Minn.-based sanitization products and services company said the $260 million acquisition will complement its own product offering.
Privately-held O.R. Solutions makes systems designed to lower the risk of infection during surgery by maintaining the proper temperature of fluids used in the procedures.